OBJECTIVES: This study sought to determine the association of high ankle brachial index (ABI) measurements with left ventricular (LV) mass, and to compare its strength with that of low ABI with LV mass. BACKGROUND: Arterial stiffness leads to LV mass through nonatherosclerotic pathways in mice. In humans, a high ABI indicates stiff peripheral arteries and is associated with cardiovascular disease (CVD) events. Whether high ABI is associated with LV mass in humans and whether this might reflect consequences of arterial stiffness, atherosclerosis, or both is unknown. METHODS: Among 4,972 MESA (Multi-Ethnic Study of Atherosclerosis) participants without clinical CVD, we used linear regression to evaluate the association of low (<0.90) and high (>1.40 or incompressible) ABI with LV mass by cardiac magnetic resonance imaging (MRI). Intermediate ABIs served as the reference category. To determine the effect of subclinical atherosclerosis, models were adjusted for common and internal carotid intima media thickness (cIMT) and natural log-transformed coronary artery calcification. RESULTS: Compared with subjects with intermediate ABI, LV mass was higher with either low (2.70 g/m(2) higher, 95% confidence interval: 0.65 to 4.75) or high ABI (6.84 g/m(2) higher, 95% confidence interval: 3.2 to 10.47) after adjustment for traditional CVD risk factors, kidney function, and C-reactive protein. However, further adjustment for cIMT and CAC substantially attenuated the association of low ABI with LV mass index (1.24 g/m(2) higher, 95% confidence interval: -0.84 to 3.33), whereas the association of high ABI was minimally altered (6.01 g/m(2) higher, 95% confidence interval: 2.36 to 9.67). CONCLUSIONS: High ABI is associated with greater LV mass; an association that is not attenuated with adjustment for subclinical atherosclerosis in nonperipheral arterial beds. High ABI might lead to greater LV mass through nonatherosclerotic pathways. Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
OBJECTIVES: This study sought to determine the association of high ankle brachial index (ABI) measurements with left ventricular (LV) mass, and to compare its strength with that of low ABI with LV mass. BACKGROUND: Arterial stiffness leads to LV mass through nonatherosclerotic pathways in mice. In humans, a high ABI indicates stiff peripheral arteries and is associated with cardiovascular disease (CVD) events. Whether high ABI is associated with LV mass in humans and whether this might reflect consequences of arterial stiffness, atherosclerosis, or both is unknown. METHODS: Among 4,972 MESA (Multi-Ethnic Study of Atherosclerosis) participants without clinical CVD, we used linear regression to evaluate the association of low (<0.90) and high (>1.40 or incompressible) ABI with LV mass by cardiac magnetic resonance imaging (MRI). Intermediate ABIs served as the reference category. To determine the effect of subclinical atherosclerosis, models were adjusted for common and internal carotid intima media thickness (cIMT) and natural log-transformed coronary artery calcification. RESULTS: Compared with subjects with intermediate ABI, LV mass was higher with either low (2.70 g/m(2) higher, 95% confidence interval: 0.65 to 4.75) or high ABI (6.84 g/m(2) higher, 95% confidence interval: 3.2 to 10.47) after adjustment for traditional CVD risk factors, kidney function, and C-reactive protein. However, further adjustment for cIMT and CAC substantially attenuated the association of low ABI with LV mass index (1.24 g/m(2) higher, 95% confidence interval: -0.84 to 3.33), whereas the association of high ABI was minimally altered (6.01 g/m(2) higher, 95% confidence interval: 2.36 to 9.67). CONCLUSIONS: High ABI is associated with greater LV mass; an association that is not attenuated with adjustment for subclinical atherosclerosis in nonperipheral arterial beds. High ABI might lead to greater LV mass through nonatherosclerotic pathways. Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Authors: J Jeffrey Carr; Jennifer Clark Nelson; Nathan D Wong; Michael McNitt-Gray; Yadon Arad; David R Jacobs; Stephan Sidney; Diane E Bild; O Dale Williams; Robert C Detrano Journal: Radiology Date: 2005-01 Impact factor: 11.105
Authors: N Niederhoffer; I Lartaud-Idjouadiene; P Giummelly; C Duvivier; R Peslin; J Atkinson Journal: Hypertension Date: 1997-04 Impact factor: 10.190
Authors: D H O'Leary; J F Polak; S K Wolfson; M G Bond; W Bommer; S Sheth; B M Psaty; A R Sharrett; T A Manolio Journal: Stroke Date: 1991-09 Impact factor: 7.914
Authors: Ramin Shadman; Michael H Criqui; Warner P Bundens; Arnost Fronek; Julie O Denenberg; Anthony C Gamst; Mary M McDermott Journal: J Am Coll Cardiol Date: 2004-08-04 Impact factor: 24.094
Authors: Payman Zamani; Scott M Lilly; Patrick Segers; David R Jacobs; David A Bluemke; Daniel A Duprez; Julio A Chirinos Journal: J Card Fail Date: 2016-04-19 Impact factor: 5.712
Authors: Payman Zamani; David R Jacobs; Patrick Segers; Daniel A Duprez; Lyndia Brumback; Richard A Kronmal; Scott M Lilly; Raymond R Townsend; Matthew Budoff; Joao A Lima; Peter Hannan; Julio A Chirinos Journal: Hypertension Date: 2014-08-04 Impact factor: 10.190
Authors: Faisal A Arain; Zi Ye; Kent R Bailey; Qian Chen; Guanghui Liu; Cynthia L Leibson; Iftikhar J Kullo Journal: J Am Coll Cardiol Date: 2012-01-24 Impact factor: 24.094
Authors: Michael H Criqui; Victor Aboyans; Matthew A Allison; Julie O Denenberg; Nketi Forbang; Mary M McDermott; Christina L Wassel; Nathan D Wong Journal: Glob Heart Date: 2016-09
Authors: Kunihiro Matsushita; Shoshana H Ballew; Yingying Sang; Corey Kalbaugh; Laura R Loehr; Alan T Hirsch; Hirofumi Tanaka; Gerardo Heiss; B Gwen Windham; Elizabeth Selvin; Josef Coresh Journal: Atherosclerosis Date: 2016-11-23 Impact factor: 5.162
Authors: Jeffrey J Hsu; Ronit Katz; Joachim H Ix; Ian H de Boer; Bryan Kestenbaum; Michael G Shlipak Journal: Nephrol Dial Transplant Date: 2014-04-29 Impact factor: 5.992
Authors: Scott M Lilly; David R Jacobs; Richard Kronmal; David A Bluemke; Michael Criqui; Joao Lima; Matthew Allison; Daniel Duprez; Patrick Segers; Julio A Chirinos Journal: Atherosclerosis Date: 2014-02-12 Impact factor: 5.162
Authors: Michael E Seifert; Lisa de Las Fuentes; Charles Ginsberg; Marcos Rothstein; Dennis J Dietzen; Steven C Cheng; Will Ross; David Windus; Victor G Dávila-Román; Keith A Hruska Journal: Am J Nephrol Date: 2014-05-06 Impact factor: 3.754